BIOMAT Database Logo BIOMAT Database Logo

INHIBITION OF RESISTANT DYSENTERY BACILLI BY PHLEOMYCIN. 1963

T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA

UI MeSH Term Description Entries
D010600 Pharmacology The study of the origin, nature, properties, and actions of drugs and their effects on living organisms. Pharmacologies
D010692 Phleomycins Water-soluble, copper-containing low molecular weight polypeptides obtained from the culture medium of Streptomyces verticillus. They are specific inhibitors of DNA synthesis in bacteria and have been found to act as antitumor agents. They have also been used against rust fungi of plants. Phleomycin
D012106 Research Critical and exhaustive investigation or experimentation, having for its aim the discovery of new facts and their correct interpretation, the revision of accepted conclusions, theories, or laws in the light of newly discovered facts, or the practical application of such new or revised conclusions, theories, or laws. (Webster, 3d ed) Research Priorities,Laboratory Research,Research Activities,Research and Development,Activities, Research,Activity, Research,Development and Research,Priorities, Research,Priority, Research,Research Activity,Research Priority,Research, Laboratory
D004405 Dysentery, Bacillary DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest). Shigellosis,Dysentery, Shiga bacillus,Dysentery, Shigella boydii,Dysentery, Shigella dysenteriae,Dysentery, Shigella dysenteriae type 1,Dysentery, Shigella flexneri,Dysentery, Shigella sonnei,Shigella Dysentery,Shigella Infection,Bacillary Dysentery,Dysenteries, Shigella,Dysenteries, Shigella boydii,Dysenteries, Shigella dysenteriae,Dysenteries, Shigella flexneri,Dysenteries, Shigella sonnei,Dysentery, Shigella,Infection, Shigella,Infections, Shigella,Shiga bacillus Dysentery,Shigella Dysenteries,Shigella Infections,Shigella boydii Dysenteries,Shigella boydii Dysentery,Shigella dysenteriae Dysenteries,Shigella dysenteriae Dysentery,Shigella flexneri Dysenteries,Shigella flexneri Dysentery,Shigella sonnei Dysenteries,Shigella sonnei Dysentery
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D012760 Shigella A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that ferments sugar without gas production. Its organisms are intestinal pathogens of man and other primates and cause bacillary dysentery (DYSENTERY, BACILLARY).

Related Publications

T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
[Shifts in drug-resistant dysentery bacilli and the therapy of dysentery].
June 1963, [Sogo rinsho] Clinic all-round,
T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
Infections by dysentery bacilli.
December 1947, Revista de sanidad,
T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
[COMBINED USE OF MATROMYCIN AND PANFRAN S DYSENTERY BACILLI. (1). WITH SPECIAL REFERENCE TO THERAPEUTIC EXPERIENCES OF RESISTANT DYSENTERY BACILLI].
October 1964, Nihon Densenbyo Gakkai zasshi,
T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
[Cell penetration by dysentery bacilli (author's transl)].
November 1977, Nihon saikingaku zasshi. Japanese journal of bacteriology,
T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
[On the therapeutic effectiveness of sigmamycin in patients with dysentery caused by drug-resistant bacilli].
October 1962, The Journal of antibiotics. Ser. B,
T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
[On the incidence of detection of carriers of levomycetin-resistant dysentery bacilli].
September 1965, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
The Atypical Dysentery Bacilli.
April 1919, The Journal of hygiene,
T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
Serological Identification of Dysentery Bacilli.
June 1944, American journal of public health and the nation's health,
T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
Immune processes induced by dysentery bacilli in mice.
January 1978, Archivum immunologiae et therapiae experimentalis,
T TAKEUCHI, and M ISHIZUKA, and Y YAMAZAKI, and H UMEZAWA
STUDIES ON THE BACTERIOPHAGE OF D'HERELLE : X. TOXIN PRODUCTION BY NORMAL AND BY PHAGE-RESISTANT SHIGA DYSENTERY BACILLI.
July 1928, The Journal of experimental medicine,
Copied contents to your clipboard!